Dataset Viewer
Auto-converted to Parquet Duplicate
id
stringlengths
9
11
source
stringclasses
1 value
title
stringlengths
15
560
text
stringlengths
2k
153k
PMC7766849
core_pubmed_pmc
Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico
Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico Abstract Background: The aim of this analysis was to characterize the pharmacokinetics (PK) of sublingual buprenorphine (BUP) and its metabolites (buprenorp...
PMC5683787
core_pubmed_pmc
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia Abstract Aims Paliperidone palmitate 3-month (PP3M) represents a new long-acting injectable antipsychotic therapeutic option. This review aims: 1) to summarize available data relating to efficacy, safety, tolerability and costs of...
PMC11452728
core_pubmed_pmc
Pharmacokinetics of pulmonary indacaterol in rat lung using molecular imprinting solid-phase extraction coupled with RP-UPLC
Pharmacokinetics of pulmonary indacaterol in rat lung using molecular imprinting solid-phase extraction coupled with RP-UPLC Abstract Abstract Indacaterol, a β 2 agonist prescribed for long-term management of patients with chronic obstructive pulmonary disease and asthma. In this study the first MISPE cartridges was de...
PMC6817585
core_pubmed_pmc
Simultaneous Determination of Five Alkaloids by HPLC-MS/MS Combined With Micro-SPE in Rat Plasma and Its Application to Pharmacokinetics After Oral Administration of Lotus Leaf Extract
Simultaneous Determination of Five Alkaloids by HPLC-MS/MS Combined With Micro-SPE in Rat Plasma and Its Application to Pharmacokinetics After Oral Administration of Lotus Leaf Extract Abstract Abstract An environment-friendly and efficient method for simultaneous determination of five alkaloids (nunciferine, O-nornuci...
PMC8290316
core_pubmed_pmc
A Promising Anticancer Agent Dimethoxycurcumin: Aspects of Pharmacokinetics, Efficacy, Mechanism, and Nanoformulation for Drug Delivery
A Promising Anticancer Agent Dimethoxycurcumin: Aspects of Pharmacokinetics, Efficacy, Mechanism, and Nanoformulation for Drug Delivery Abstract Abstract Curcumin is a well-known anticancer natural product with various significant bioactivities that has been well documented, but its widespread use is mainly hindered by...
PMC11646931
core_pubmed_pmc
Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients
Application of physiologically‐based pharmacokinetic modeling to inform dosing decisions for geriatric patients Modeling HOW CAN PBPK MODELS BE EXTRAPOLATED TO GERIATRIC PATIENTS WITH MULTIPLE COMORBIDITIES? Aging is often accompanied by changes in the anatomy and physiology of multiple tissues and organs. Consideratio...
PMC4559582
core_pubmed_pmc
Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety Abstract Background and Objective Oral levodopa-carbidopa (LC-oral) treatment in advanced Parkinson’s dise...
PMC11040043
core_pubmed_pmc
Petroselinum crispum L ., essential oil as promising source of bioactive compounds, antioxidant, antimicrobial activities : In vitro and in silico predictions
Petroselinum crispum L ., essential oil as promising source of bioactive compounds, antioxidant, antimicrobial activities : In vitro and in silico predictions Abstract Abstract This exploratory study aims to identify the volatile compounds in PC-Eo ( Petroselinum crispum L. essential oil) and evaluate its antioxidant a...
PMC6369847
core_pubmed_pmc
Combined administration of PTX and S-HM-3 in TPGS/Solutol micelle system for oncotarget therapy
Combined administration of PTX and S-HM-3 in TPGS/Solutol micelle system for oncotarget therapy Abstract Background S-HM-3 is a tumor angiogenesis inhibitor with short half-life (25 min). In this present, TPGS/Solutol polymeric micelles was prepared to load together insoluble paclitaxel (PTX) and soluble S-HM-3, expect...
PMC5484109
core_pubmed_pmc
A Study of 11-[ 3 H]-Tetrodotoxin Absorption, Distribution, Metabolism and Excretion (ADME) in Adult Sprague-Dawley Rats
A Study of 11-[ 3 H]-Tetrodotoxin Absorption, Distribution, Metabolism and Excretion (ADME) in Adult Sprague-Dawley Rats Abstract Tetrodotoxin (TTX) is a powerful sodium channel blocker that in low doses can safely relieve severe pain. Studying the absorption, distribution, metabolism and excretion (ADME) of TTX is cha...
PMC11434395
core_pubmed_pmc
A Multi-Spectroscopic and Molecular Docking Analysis of the Biophysical Interaction between Food Polyphenols, Urolithins, and Human Serum Albumin
A Multi-Spectroscopic and Molecular Docking Analysis of the Biophysical Interaction between Food Polyphenols, Urolithins, and Human Serum Albumin Abstract Secondary polyphenol metabolites, urolithins (UROs), have anti-oxidative, anti-inflammatory, and antidiabetic properties. Therefore, their biological activity relies...
PMC10671567
core_pubmed_pmc
Evaluation of Biological Equivalence for Generic Tulathromycin Injections in Cattle
Evaluation of Biological Equivalence for Generic Tulathromycin Injections in Cattle Abstract Abstract The recent expiration of patents for the antibiotic tulathromycin has led to a significant increase in the number of generic tulathromycin products (GTPs) available. This study aims to evaluate the bioequivalence of fo...
PMC10417861
core_pubmed_pmc
Alternate Antimicrobial Therapies and Their Companion Tests
Alternate Antimicrobial Therapies and Their Companion Tests Abstract Abstract New antimicrobial approaches are essential to counter antimicrobial resistance. The drug development pipeline is exhausted with the emergence of resistance, resulting in unsuccessful trials. The lack of an effective drug developed from the co...
PMC9706311
core_pubmed_pmc
Prediction of total and renal clearance of renally secreted drugs in neonates and infants (≤3 months of age)
Prediction of total and renal clearance of renally secreted drugs in neonates and infants (≤3 months of age) Abstract Abstract Background: Renal excretion is a major route of elimination for many drugs. Renal clearance is the sum of three processes: glomerular filtration, tubular secretion, and tubular re-absorption. T...
PMC5062546
core_pubmed_pmc
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans Abstract Abstract Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2....
PMC5048094
core_pubmed_pmc
Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model
Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model Abstract Abstract The purpose of the present study was to evaluate the neuroprotective efficacy of optimized thymoquinone loaded PLGA-chitosan nanoparticles delivered via nose to brain route in the rod...
PMC7406636
core_pubmed_pmc
In vivo and in silico characterization of apocynin in reducing organ oxidative stress: A pharmacokinetic and pharmacodynamic study
In vivo and in silico characterization of apocynin in reducing organ oxidative stress: A pharmacokinetic and pharmacodynamic study Abstract Abstract Apocynin has been widely used in vivo as a Nox2‐contaninig nicotinamide adenine dinucleotide phosphate oxidase inhibitor. However, its time‐dependent tissue distribution a...
End of preview. Expand in Data Studio

PKPD Dataset

Dataset summary

This dataset is a pharmacokinetics/pharmacodynamics (PK/PD) and pharmacometrics corpus built for domain-adaptive pretraining (DAPT).

It was created from automatically downloadable biomedical literature using:

  • PubMed search via NCBI E-utilities
  • PMID to PMCID mapping via the official PMC id conversion service
  • Europe PMC / PMC open-access full-text XML retrieval
  • JATS/XML parsing and heuristic filtering

The current released corpus contains 27,990 documents and approximately 109.4 million estimated tokens.

This release contains only the core PubMed/PMC open-access article corpus. Optional FDA guidance and open-source repository documentation were implemented in the pipeline but are not included in the current dataset export.

Scope

The search strategy targets:

  • pharmacokinetics
  • pharmacodynamics
  • PK/PD modeling
  • population PK/PD
  • nonlinear mixed effects modeling
  • NONMEM / Monolix / SAEM / FOCE / NLME
  • PBPK
  • exposure-response
  • dose selection
  • model-informed drug development
  • clinical pharmacology
  • covariate modeling
  • Bayesian PKPD

The corpus is intended for:

  • domain-adaptive pretraining
  • continued pretraining of biomedical or general LLMs
  • information retrieval / RAG experiments
  • corpus analysis for pharmacometrics language

Source data and collection pipeline

Source systems

Primary source systems used for this release:

  1. PubMed / NCBI E-utilities
  2. PMC ID conversion API
  3. Europe PMC fullTextXML endpoint

Excluded from this release:

  • paywalled journal scraping
  • copyrighted textbook scraping
  • FDA guidance pages
  • open-source repository docs

Date range

  • Search period: 2010-01-01 to 2026-03-12

Query families

The PubMed search used five overlapping query families:

  1. pkpd_core
  2. population_pkpd
  3. nlme_platforms
  4. pbpk
  5. exposure_response_midd

Per-query unique PMID counts before cross-query deduplication:

Query family Unique PMIDs
pkpd_core 145,533
population_pkpd 6,847
nlme_platforms 3,932
pbpk 4,951
exposure_response_midd 12,331

After deduplication across query families, the search yielded:

  • 156,274 unique PMIDs

Retrieval and filtering stages

Pipeline totals:

  1. PubMed search: 156,274 unique PMIDs
  2. PMID to PMCID mapping: 66,948 PMCIDs
  3. Europe PMC / PMC XML retrieved: 49,097 XML articles
  4. Parsed JATS records: 49,097
  5. Final kept DAPT documents: 27,990

Retrieval outcomes:

  • PMCIDs with XML successfully materialized locally: 49,097
  • PMCIDs mapped but not available through Europe PMC fullTextXML: 18,215
  • Fetch failures: 0 at the end of the completed run

Filtering outcomes:

  • Parsed input docs: 49,097
  • Final kept docs: 27,990
  • Rejected for low relevance: 19,052
  • Rejected for too short length: 2,054
  • Rejected as duplicates: 1

Data fields

Each record in the final JSONL contains:

  • id: document identifier, usually PMCID-based
  • source: source group
  • title: article title
  • text: cleaned training text

Example schema:

{
  "id": "PMC10010492",
  "source": "core_pubmed_pmc",
  "title": "Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia",
  "text": "..."
}

Split / repartition

Current files on disk:

  • final_merged_dapt.jsonl: 27,990 records
  • train.jsonl: 27,431 records
  • eval.jsonl: 559 records

Split proportions:

  • Train: 27,431 / 27,990 = 98.0%
  • Validation: 559 / 27,990 = 2.0%

Source repartition in the final release:

Source Documents Share
core_pubmed_pmc 27,990 100%

Character / token scale:

  • Total characters: 437,602,093
  • Average characters per kept document: 15,638.38
  • Rough token estimate: 109,400,619

Text extraction details

The XML parser keeps article components most useful for PKPD DAPT:

  • title
  • abstract
  • methods
  • modeling
  • statistical analysis
  • results
  • discussion
  • conclusion

The parser drops low-value or non-training sections when possible:

  • references
  • acknowledgements
  • funding boilerplate
  • author contributions
  • supplementary boilerplate

Whitespace is normalized, and some inline citation clutter is removed.

Quality notes

This corpus was built with high recall rather than high precision. It is strong for:

  • PK/PD language
  • clinical pharmacology
  • PBPK
  • exposure-response
  • dose optimization
  • drug disposition and modeling methods

However, the query strategy is broad, and some retained articles are only adjacent to pharmacometrics rather than strictly within it. For example, some documents concern:

  • broader translational pharmacology
  • oncology therapeutics
  • drug-protein binding
  • formulation or delivery topics

This makes the dataset suitable for a prototype DAPT corpus, but not yet a perfectly clean pharmacometrics-only benchmark.

Intended uses

Recommended uses:

  • domain-adaptive pretraining for LLMs
  • continued pretraining of Qwen/Llama/Mistral-style causal LMs
  • corpus mining and keyword analysis
  • retrieval experiments on PKPD literature

Not recommended as-is for:

  • strict pharmacometrics benchmarking without extra curation
  • legal redistribution assumptions without checking article-level terms
  • clinical decision support

Licensing and redistribution note

This dataset is derived from PMC / Europe PMC open-access full-text XML and related PubMed metadata, but the corpus should not be interpreted as having a single unified license automatically inherited across all articles.

Important note:

  • PMC / Europe PMC accessibility does not guarantee identical downstream redistribution terms for every document.
  • Before making the dataset public, article-level licensing and redistribution conditions should be reviewed carefully.

For conservative use, private hosting is recommended until licensing is fully audited.

Reproducibility

The dataset was generated by the local pipeline in:

  • scripts/01_search_pubmed.py
  • scripts/02_map_pmids_to_pmcids.py
  • scripts/03_fetch_fulltext_xml.py
  • scripts/04_parse_jats_xml.py
  • scripts/05_build_dapt_jsonl.py
  • scripts/08_merge_and_report.py

Summary reports used for this card:

  • data/reports/pubmed_search_summary.json
  • data/reports/fulltext_retrieval_report.json
  • data/reports/parsed_xml_report.json
  • data/reports/core_pubmed_build_report.json
  • data/reports/corpus_summary.json

Loading example

from datasets import load_dataset

ds = load_dataset("Khalilbraham/PKPD-Dataset")
print(ds)
print(ds["train"][0].keys())

Suggested citation

If you use this dataset, cite:

  1. PubMed / NCBI E-utilities
  2. PMC / Europe PMC
  3. The dataset repository itself

You may also cite the associated local corpus-building pipeline if released separately.

Downloads last month
25